1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
AptarGroup, Inc.

AptarGroup, Inc.

ATR
AptarGroup, Inc.US flagNew York Stock Exchange
112.53
USD
+0.35
- -
7.18BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
38.13
39.96
37.02
37.11
39.55
44.28
44.98
45.47
49.15
50.8
53.15
54.01
57.46
59.41
Basic EPS, GAAP
2.6
2.95
3.19
3.27
3.52
3.12
3.81
3.32
3.72
3.66
4.34
5.65
5.97
5.93
Free Cash Flow per Basic Share
4.32
4.87
5.17
5.14
5.2
5.01
8.02
8.76
5.53
7.24
8.67
9.43
8.59
9.25
Dividend per Share
1
1.09
1.14
1.22
1.28
1.32
1.42
1.44
1.5
1.52
1.58
1.72
1.84
1.87
Book Value per Share
24.52
26.78
18.96
19.07
20.85
21.98
23.98
25.53
27.26
29.51
32.16
35.75
40.21
41.19
Tangible Book Value per Share
16.21
11.29
12.91
10.7
12.38
7.3
8.14
9.44
9.87
12.34
16.38
19.52
20.98
20.82
Basic Weighted Avg Shares
66
65
63
63
62
62
64
64
66
65
66
66
66
65
Sales/Revenue/Turnover
2,520
2,598
2,317
2,331
2,469
2,765
2,860
2,929
3,227
3,322
3,487
3,583
3,777
3,873
Operating Margin (%)
11.76
11.8
13.99
13.46
13.19
12.66
13.71
12.49
11.48
11.61
12.88
14.22
13.53
13.01
Depreciation Expense
150
152
139
155
153
172
195
220
235
234
249
264
287
297
Net Income, GAAP
172
192
199
206
220
195
242
214
244
239
284
375
393
387
Effective Tax Rate (%)
34.97
33.07
32.34
26.7
25.37
26.79
29.19
28.91
24.25
28.43
24.18
20.35
20.12
19.31
Profit Margin (%)
6.83
7.38
8.6
8.82
8.91
7.04
8.47
7.31
7.56
7.2
8.16
10.45
10.4
9.98
Working Capital
656
609
883
727
1,142
642
608
589
376
513
298
410
727
705
LT Debt
355
589
761
773
1,191
1,126
1,141
1,107
955
1,096
726
738
1,187
1,187
Total Equity
1,480
1,104
1,150
1,174
1,312
1,423
1,572
1,851
1,985
2,068
2,321
2,486
2,712
2,674
Return on Invested Capital (%)
10.22
10.49
11.23
11.26
10.38
9.72
10.05
8.84
8.92
8.5
10.06
11.54
10.5
10.62
Return on Capital (%)
9.14
8.76
9.72
11.15
10.64
8.37
9.83
8.42
9.04
8.64
9.75
12.11
11.33
11.37
Return on Common Equity (%)
10.97
11.4
13.62
17.25
17.6
14.56
16.72
13.51
14.21
12.86
14.08
16.71
15.67
15.15

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
655
344
222
LT Borrowings
546
1,139
1,143
LT Finance Leases
49
48
44
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
66
64
64
Market Capitalization
8,838
8,018
8,215

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
1,784
1,894
1,768
Cash, Cash Equivalents & STI
265
410
229
Accounts Receivable, Net
799
804
833
Inventories
547
538
551
Total Current Liabilities
1,499
1,166
1,063
Payables & Accruals
845
515
841
ST Debt
655
344
222
Deferred Revenue
- -
75
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.04%
7.97%
9.1%
Free Cash Flow
8.53%
3.03%
-9.71%
Net Income, GAAP
7.89%
13.5%
4.87%
Sales/Revenue/Turnover
5.06%
5.25%
5.42%
Total Cash Common Dividend
5.46%
5.48%
5.9%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
915
910
909
848
3,583
2025
887
966
961
963
3,777
2026
983
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.26
1.36
1.51
1.52
5.65
2025
1.19
1.69
1.95
1.14
5.97
2026
1.13
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.41
0.41
0.45
0.45
1.72
2025
0.45
0.45
0.45
0.48
1.84
2026
0.48
- -
- -
- -
- -

Company Description

APIChat
CEO
Stephan Tanda
Full Time Employees
13,000
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
265 Exchange Drive Crystal Lake IL United States of America 60014
IPO Date
Apr 23, 1993
CIK
0000896622
Website
aptar.com
Similar Companies
Encision Inc. (ECIA)
Crystalvue Medical Corporation (6527.TWO)
I.ceram S.A. (ALICR.PA)
Baxter International Inc. (0QK8.L)
LifePoint, Inc. (LFPI)
Mercator Medical S.A. (MRC.WA)
Business
AptarGroup, Inc. designs, manufactures and markets a broad range of drug delivery systems, consumer product dispensing systems, active material science solutions and sealing, packaging services for the pharmaceutical, beauty, personal care, home care, food and beverage industries worldwide. The company operates through three main segments: Aptar Pharma, which provides nasal and pulmonary drug delivery devices including pumps for nasal allergy treatments, metered-dose inhaler valves for respiratory conditions such as asthma and chronic obstructive pulmonary disease, elastomers for injectable packaging components, proprietary Unidose and Bidose intranasal delivery systems, aerosol valves, digital health solutions and clinical trial materials manufacturing services; Aptar Beauty, which offers dispensing pumps, closures, pouch spouts, spray pumps and valves for fragrance, make-up, skincare and cleansing products; and Aptar Closures, which supplies dispensing closures, dosing cups, droppers and other packaging solutions. AptarGroup sells its products primarily in North America, Europe, Asia and Latin America; the company was incorporated in 1992 and maintains headquarters in Crystal Lake, Illinois, with manufacturing facilities and over 13,000 employees across 20 countries. Recently, Aptar Pharma acquired the device technology assets of SipNose Nasal Delivery Systems in November 2025 to expand its intranasal drug delivery portfolio for local, systemic and central nervous system indications including nose-to-brain pathways; acquired clinical trial materials manufacturing capabilities of Mod3 Pharma in July 2025 to enhance Phase 1 and 2 formulation, fill-finish services for orally inhaled and nasal drug products at an FDA-inspected facility in Boonton, New Jersey; acquired Brazilian pharmaceutical packaging firm Sommaplast in December 2025 to strengthen oral dosing solutions such as closures, droppers, dispensers and dosing cups amid growth in over-the-counter and nutraceutical markets; issued approximately $600 million in senior unsecured notes due 2031 in November 2025 to bolster financial flexibility for operations and acquisitions; and extended collaboration with Nasus Pharma on intranasal epinephrine devices.

Company News

APIChat

  • seekingalpha.com

    AptarGroup, Inc. (ATR) Presents at Jefferies Global Healthcare Conference 2026 Transcript

  • businesswire.com

    Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year

  • businesswire.com

    Aptar to Participate in Upcoming Investor Conferences

  • marketbeat.com

    AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot

  • zacks.com

    AptarGroup Q1 Earnings Beat Estimates but Decline Y/Y, Shares Dip 1%

  • globenewswire.com

    Advanced Technology Recycling (ATR) Announces That They Are Now Offering Wholesale Electronics to the General Public Through Their Online Auction Site

  • gurufocus.com

    Is AptarGroup Inc (ATR) a Bargain After 3.8% Drop? GF Value Says Undervalued

  • seekingalpha.com

    AptarGroup, Inc. (ATR) Q1 2026 Earnings Call Transcript

  • zacks.com

    AptarGroup (ATR) Beats Q1 Earnings and Revenue Estimates

  • businesswire.com

    Aptar Reports First Quarter 2026 Results

  • zacks.com

    Avery Dennison Q1 Earnings Top Estimates on Volume Gains, Cost Control

  • zacks.com

    Analysts Estimate Graphic Packaging (GPK) to Report a Decline in Earnings: What to Look Out for

  • zacks.com

    Avery Dennison (AVY) Q1 Earnings and Revenues Surpass Estimates

  • defenseworld.net

    Cwm LLC Purchases 5,457 Shares of AptarGroup, Inc. $ATR

  • businesswire.com

    Aptar Declares Quarterly Dividend

  • zacks.com

    Earnings Preview: AptarGroup (ATR) Q1 Earnings Expected to Decline

  • globenewswire.com

    Rakovina Therapeutics Presents New Preclinical Data at AACR 2026 Annual Meeting

  • globenewswire.com

    Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution

  • defenseworld.net

    SG Americas Securities LLC Increases Stock Holdings in AptarGroup, Inc. $ATR

  • zacks.com

    New Strong Sell Stocks for March 26th